Home » Topics » BioWorld Science

BioWorld Science
RSS

Trivalent PROTAC SIM-1 shows enhanced BET degradation and cytotoxicity

Nov. 11, 2021

TQS-168 extends survival in mouse model of ALS

Nov. 11, 2021

Researchers develop CFTR-mutated cystic fibrosis murine model to allow gene-editing strategies

Nov. 11, 2021

XuanZhu Pharma divulges new DNA-dependent protein kinase inhibitors

Nov. 11, 2021

New GnRH-R antagonists identified at Shanghai Innofortune Biotech

Nov. 11, 2021

SyneuRx International patents DAAO and/or 3C-like proteinase inhibitors

Nov. 11, 2021

PharmaBlock Sciences discovers p300 and CREBBP inhibitors

Nov. 11, 2021

New NMDA receptor antagonists described by Suzhou Nhwa Biomedical Technology

Nov. 11, 2021

SUVN-4404091 shows efficacy in rat model of amphetamine-induced hyperlocomotion

Nov. 11, 2021

UBE-1099: a novel Keap1-Nrf2 PPI inhibitor for kidney disease

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...